The global thiamine industry value is forecast to increase from US$ 1,166.2 million in 2023 to US$ 2,356.8 million by 2033. Over the assessment period, global demand for thiamine is projected to surge at a CAGR of 7.2%.
Thiamine mononitrate segment is expected to dominate the global thiamine industry through 2033. It will likely hold a volume share of 77.1% by 2023. This is due to rising usage of thiamine mononitrate in diverse sectors.
The demand for thiamine, also known as vitamin B1, is driven by its essential role in supporting human health and well-being. Thiamine is involved in vital bodily functions, including energy metabolism and the proper functioning of the nervous system.
Get Ahead with Our Report: Request Your Sample Now:
https://www.futuremarketinsights.com/reports/sample/rep-gb-15349
The increasing awareness of the importance of a balanced diet and the role of vitamins in overall health is expected to propel the demand for thiamine-containing products. This, in turn, will foster growth of the thiamine industry.
The food and beverage industry is witnessing high demand for thiamine-fortified products as manufacturers respond to consumer preferences for nutritionally enhanced options. The pharmaceutical sector relies on thiamine to formulate medications and supplements addressing thiamine deficiencies and related health conditions.
Growing usage of thiamine in the personal care industry is another key factor expected to boost the market. Thiamine possesses antioxidant properties that may help protect the skin from oxidative stress.
The global market for thiamine continues to grow as health-conscious consumers seek products that support and fulfill their nutritional needs. Whether through fortified foods, dietary supplements, or pharmaceutical formulations, the demand for thiamine remains robust.
The research continues to uncover new facets of thiamine’s benefits. As industries adapt to evolving consumer needs, thiamine’s influence is poised to remain significant in shaping the future of nutrition, healthcare, and several industrial sectors worldwide.
Key Takeaways from the Thiamine Market Report
- The global market for thiamine is projected to thrive at 2% CAGR through 2033.
- By product type, the thiamine mononitrate segment is expected to total US$ 1,996.7 million by 2033.
- By end use, the food and beverage segment is set to hold a market share of 9%in 2023.
- East Asia is expected to account for a significant share of about 6%in 2033.
- Sales in the United States are predicted to total US$ 344.5 million by 2033.
- China is set to attain a valuation of US$ 577.4 million by 2033.
- Demand in India is predicted to rise at 1% CAGR through 2033.
“The global thiamine industry is poised to witness healthy growth due to escalating government regulations on food products, expanding industrial sectors, and increasing emphasis on importance of thiamine in daily diet.” – says an analysis at Future Market Insights (FMI).
Who is Winning?
DSM Nutritional Products, Brother Enterprises Holding Co. Ltd., BASF SE, CSPC Pharmaceutical Group Ltd, Tianjin Pharmaceutical Group, Huazhong Pharmaceutical, Tianxin Pharmaceutical, and Shouguang Fukang are the leading manufacturers of thiamine profiled in the full version of the report.
Key players focus on expanding thiamine’s domestic production and technology areas to provide consumers with cost-efficient solutions. They are also investing in developing new products and further innovating existing ones to meet end-user demand.
Recent developments:
- In January 2023,BASF and Cargill collaborated to bid high-performance enzyme solutions to several animal protein producers in the United States.
Drive Your Business Growth Strategy: Purchase the Report for Key Insights:
https://www.futuremarketinsights.com/checkout/15349
Key Companies Profiled
- BASF SE
- DSM Nutritional Products
- Lonza Group AG
- Tianjin Pharmaceutical Group
- Huazhong Pharmaceutical
- Shouguang Fukang Pharmaceutical Co., Ltd.
- Jiangxi Tianxin Pharmaceutical Co., Ltd.
- Brother Enterprises Holding Co., Ltd
- Zhejiang NHU Co., Ltd.
- CSPC Pharmaceutical Group
- Xinfa Pharmaceutical Co., Ltd.
More Insights into the Thiamine Market Report
In its latest report, Future Market Insights (FMI) offers an unbiased analysis of the global thiamine market, providing historical data from 2018 to 2022 and forecast statistics for the period 2023 to 2033.
To understand the global thiamine market potential, growth, and scope, the market is segmented based on product type (thiamine mononitrate and thiamine hydrochloride), end use (food and beverages, animal feed, pharmaceuticals, personal care, and others), and region (North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, Middle East and Africa)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
